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Problem Identification
 Influenza carries a high morbidity and mortality1
 Annual US hospitalizations: 140,000-710,000
 Annual US deaths: 12,000-56,000 
 Adults over 65 years are at increased risk with 90% of influenza-related deaths
 While adults over 65 years old are most at risk from influenza, they also are the 
population in which the standard-dose influenza vaccine is least efficacious 
due to the decline in immune function with aging.2
 High-Dose influenza Vaccine has been approved by the FDA for use in adults 65 
and older and has been shown to reduce:




 Mortality from influenza8
Problem identification - Waterville
 While high-dose influenza vaccine is shown to be more effective, it has not 
been widely utilized by the primary care providers of Inland Hospital.6
 In the 2016-2017 season, a total of 600 high-dose flu vaccines were utilized 
by Inland Hospital for 5,197 patients over 65 years old.9
Public Health Cost (US) of Influenza
 Direct medical costs:  $10.4 billion annually. 
 Projected lost earnings due to illness and loss of life: $16.3 billion annually. 
 Total economic burden of annual influenza epidemics using projected 
statistical life values: $87.1 billion.10
Community Perspective
 “Influenza carries a tremendous morbidity and mortality for our community. 
The high-dose influenza vaccine is currently under-utilized by our outpatient 
practices and is a valuable tool for prevention.”
- Sara Donovan, RN, Infection Preventionist, Inland Hospital6
 The low high-dose vaccine utilization rate at Inland hospital led to a waste 
of healthcare dollars at Inland Hospital. 
“For the high-dose flu vaccine in 2016-2017 I purchased 1500 doses and 
only 600 doses were given to patients. At $45.00 per dose that’s a huge 
loss.” 
- John Merchant, Pharm D, Director of Pharmacy, Inland Hospital9
Intervention and Methodology
 In order to increase awareness of the data about the use of high-dose 
influenza vaccine, a Power Point presentation was created and delivered 
to the primary care providers of Inland Hospital at one of their regularly 
scheduled monthly meetings. 
 I obtained data from Inland Pharmacy – the supplier of the high-dose 
influenza vaccines to all Inland outpatient practices – about the number of 
high-dose influenza vaccines ordered in the 2016-2017 season as well as the 
2017-2018 season.
 I obtained data from the outpatient practices to assess how many high-
dose influenza vaccines each practice administered in both the 2016-2017 
and 2017-2018 season.
Results
Practice 2016-2017 # high-dose 
influenza vaccines 
administered
2017-2018 # high-dose 
influenza vaccines 
administered
Inland Health Madison 36 135
Inland Health Unity 20 25
Inland Health Oakland 50 400
Inland Health Waterville 350 620
Results (continued)
 Inland Hospital Pharmacy Data
Flu Season Doses Ordered Doses utilized
2016-2017 1500 600
2017-2018 1350 1350
Evaluation of Effectiveness and 
Limitations
 Utilization of high-dose influenza vaccines increased by a factor of 2.25 
between the 2016-17 and 2017-18. 
 Approximately 25% of Inland primary care patients over the age of 65 
received the high dose flu vaccine in the 2017-2018 flu season as 
compared with 11.5% in the 2016-2017 season.
 Increase was supported by the Power Point presentation delivered at the 
family medicine meeting in September though that is an association and 
not causal.
 Several other factors encouraged the increase usage including:
 Patient request of the vaccine prompted by increased advertising on television 
and other media. 
 Email communications between the chief medical officer of Inland Hospital and 
primary care providers providing data about and encouraging use of high-dose 
influenza vaccine 
Recommendations for future 
intervention
 As familiarity with high-dose influenza vaccine grows among both providers 
and patients, utilization should increase. However, reminders at the 
beginning of future influenza seasons as the vaccinations are starting to be 
administered, some communication with providers would be appropriate.
 High-dose influenza vaccine is not currently administered to hospitalized 
patients at Inland Hospital. This could be offered in future flu seasons and 
would increase the utilization.
 Future community projects could include:
 Evaluation of the effectiveness of high-dose influenza vaccine in the local area 
as compared with the effectiveness of standard-dose influenza vaccine. 
 Patient-directed education materials regarding the high-dose influenza vaccine.
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Informed consent
 Thank you for agreeing to be interviewed. This project is a requirement for 
the Family Medicine clerkship. It will be stored on the Dana Library 
ScholarWorks website. Your name will be attached to your interview and 
you may be cited directly or indirectly in subsequent unpublished or 
published work. The interviewer affirms that he/she has explained the 
nature and purpose of this project. The interviewee affirms that he/she has 
consented to this interview. Yes __x___ / No _____ If not consenting as 
above: please add the interviewee names here for the department of 
Family Medicine information only. 
 Name: 
Sara Donovan, RN, Infection Preventionist, Inland Hospital
John Merchant, PharmD MHA BCPS, Director of Pharmacy - Inland Hospital
